Vor Biopharma Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: -0.02x
Net debt / equity: 1.11x
Debt / assets: 0.01x
Debt / EBITDA: 0.01x
Net debt / EBITDA: -0.37x

Liquidity & coverage

Current ratio: 31.15x
Quick ratio: 31.15x
Cash ratio: 30.57x
Interest coverage: —
EBITDA / interest: —
Working capital: $484.7M

Cash & dividend

FCF / debt: -51.26x
Cash flow / debt: -51.00x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.